AbbVie, Inc. (ABBV)
256.35
+0.87
(+0.34%)
USD |
NYSE |
Aug 31, 16:00
257.00
+0.65
(+0.25%)
After-Hours: 20:00
AbbVie Net Income (Annual) : 4.193B for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 4.193B |
| December 31, 2024 | 4.246B |
| December 31, 2023 | 4.83B |
| December 31, 2022 | 11.79B |
| December 31, 2021 | 11.48B |
| December 31, 2020 | 4.562B |
| December 31, 2019 | 7.842B |
| December 31, 2018 | 5.657B |
| December 31, 2017 | 5.283B |
| Date | Value |
|---|---|
| December 31, 2016 | 5.923B |
| December 31, 2015 | 5.118B |
| December 31, 2014 | 1.765B |
| December 31, 2013 | 4.102B |
| December 31, 2012 | 5.275B |
| December 31, 2011 | 3.433B |
| December 31, 2010 | 4.178B |
| December 31, 2009 | 4.637B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Biogen, Inc. | 1.293B |
| Gilead Sciences, Inc. | 8.51B |
| Regeneron Pharmaceuticals, Inc. | 4.505B |
| Amgen, Inc. | 7.711B |
| REGENXBIO, Inc. | -193.88M |